Testicular dysgenesis/regression without campomelic dysplasia in patients carrying missense mutations and upstream deletion of sox9

Yuko Katoh-Fukui, Maki Igarashi, Keisuke Nagasaki, Reiko Horikawa, Toshiro Nagai, Takayoshi Tsuchiya, Erina Suzuki, Mami Miyado, Kenichiro Hata, Kazuhiko Nakabayashi, Keiko Hayashi, Yoichi Matsubara, Takashi Baba, Ken Ichirou Morohashi, Arisa Igarashi, Tsutomu Ogata, Shuji Takada, Maki Fukami

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

SOX9 haploinsufficiency underlies campomelic dysplasia (CD) with or without testicular dysgenesis. Current understanding of the phenotypic variability and mutation spectrum of SOX9 abnormalities remains fragmentary. Here, we report three patients with hitherto unreported SOX9 abnormalities. These patients were identified through molecular analysis of 33 patients with 46,XY disorders of sex development (DSD). Patients 1–3 manifested testicular dysgenesis or regression without CD. Patients 1 and 2 carried probable damaging mutations p.Arg394Gly and p.Arg437Cys, respectively, in the SOX9 C-terminal domain but not in other known 46,XY DSD causative genes. These substitutions were absent from ~120,000 alleles in the exome database. These mutations retained normal transactivating activity for the Col2a1 enhancer, but showed impaired activity for the Amh promoter. Patient 3 harbored a maternally inherited ~491 kb SOX9 upstream deletion that encompassed the known 32.5 kb XY sex reversal region. Breakpoints of the deletion resided within nonrepeat sequences and were accompanied by a short-nucleotide insertion. The results imply that testicular dysgenesis and regression without skeletal dysplasia may be rare manifestations of SOX9 abnormalities. Furthermore, our data broaden pathogenic SOX9 abnormalities to include C-terminal missense substitutions which lead to target-gene-specific protein dysfunction, and enhancer-containing upstream microdeletions mediated by nonhomologous end-joining.

Original languageEnglish
Pages (from-to)550-557
Number of pages8
JournalMolecular Genetics and Genomic Medicine
Volume3
Issue number6
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Campomelic Dysplasia
Missense Mutation
XY Disorders of Sex Development 46
Mutation
Exome
Haploinsufficiency
Nucleotides
Alleles
Databases

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Testicular dysgenesis/regression without campomelic dysplasia in patients carrying missense mutations and upstream deletion of sox9. / Katoh-Fukui, Yuko; Igarashi, Maki; Nagasaki, Keisuke; Horikawa, Reiko; Nagai, Toshiro; Tsuchiya, Takayoshi; Suzuki, Erina; Miyado, Mami; Hata, Kenichiro; Nakabayashi, Kazuhiko; Hayashi, Keiko; Matsubara, Yoichi; Baba, Takashi; Morohashi, Ken Ichirou; Igarashi, Arisa; Ogata, Tsutomu; Takada, Shuji; Fukami, Maki.

In: Molecular Genetics and Genomic Medicine, Vol. 3, No. 6, 01.01.2015, p. 550-557.

Research output: Contribution to journalArticle

Katoh-Fukui, Y, Igarashi, M, Nagasaki, K, Horikawa, R, Nagai, T, Tsuchiya, T, Suzuki, E, Miyado, M, Hata, K, Nakabayashi, K, Hayashi, K, Matsubara, Y, Baba, T, Morohashi, KI, Igarashi, A, Ogata, T, Takada, S & Fukami, M 2015, 'Testicular dysgenesis/regression without campomelic dysplasia in patients carrying missense mutations and upstream deletion of sox9', Molecular Genetics and Genomic Medicine, vol. 3, no. 6, pp. 550-557. https://doi.org/10.1002/mgg3.165
Katoh-Fukui, Yuko ; Igarashi, Maki ; Nagasaki, Keisuke ; Horikawa, Reiko ; Nagai, Toshiro ; Tsuchiya, Takayoshi ; Suzuki, Erina ; Miyado, Mami ; Hata, Kenichiro ; Nakabayashi, Kazuhiko ; Hayashi, Keiko ; Matsubara, Yoichi ; Baba, Takashi ; Morohashi, Ken Ichirou ; Igarashi, Arisa ; Ogata, Tsutomu ; Takada, Shuji ; Fukami, Maki. / Testicular dysgenesis/regression without campomelic dysplasia in patients carrying missense mutations and upstream deletion of sox9. In: Molecular Genetics and Genomic Medicine. 2015 ; Vol. 3, No. 6. pp. 550-557.
@article{0f0c7061045e436b94b3d752a1fd9054,
title = "Testicular dysgenesis/regression without campomelic dysplasia in patients carrying missense mutations and upstream deletion of sox9",
abstract = "SOX9 haploinsufficiency underlies campomelic dysplasia (CD) with or without testicular dysgenesis. Current understanding of the phenotypic variability and mutation spectrum of SOX9 abnormalities remains fragmentary. Here, we report three patients with hitherto unreported SOX9 abnormalities. These patients were identified through molecular analysis of 33 patients with 46,XY disorders of sex development (DSD). Patients 1–3 manifested testicular dysgenesis or regression without CD. Patients 1 and 2 carried probable damaging mutations p.Arg394Gly and p.Arg437Cys, respectively, in the SOX9 C-terminal domain but not in other known 46,XY DSD causative genes. These substitutions were absent from ~120,000 alleles in the exome database. These mutations retained normal transactivating activity for the Col2a1 enhancer, but showed impaired activity for the Amh promoter. Patient 3 harbored a maternally inherited ~491 kb SOX9 upstream deletion that encompassed the known 32.5 kb XY sex reversal region. Breakpoints of the deletion resided within nonrepeat sequences and were accompanied by a short-nucleotide insertion. The results imply that testicular dysgenesis and regression without skeletal dysplasia may be rare manifestations of SOX9 abnormalities. Furthermore, our data broaden pathogenic SOX9 abnormalities to include C-terminal missense substitutions which lead to target-gene-specific protein dysfunction, and enhancer-containing upstream microdeletions mediated by nonhomologous end-joining.",
author = "Yuko Katoh-Fukui and Maki Igarashi and Keisuke Nagasaki and Reiko Horikawa and Toshiro Nagai and Takayoshi Tsuchiya and Erina Suzuki and Mami Miyado and Kenichiro Hata and Kazuhiko Nakabayashi and Keiko Hayashi and Yoichi Matsubara and Takashi Baba and Morohashi, {Ken Ichirou} and Arisa Igarashi and Tsutomu Ogata and Shuji Takada and Maki Fukami",
year = "2015",
month = "1",
day = "1",
doi = "10.1002/mgg3.165",
language = "English",
volume = "3",
pages = "550--557",
journal = "Molecular genetics & genomic medicine",
issn = "2324-9269",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Testicular dysgenesis/regression without campomelic dysplasia in patients carrying missense mutations and upstream deletion of sox9

AU - Katoh-Fukui, Yuko

AU - Igarashi, Maki

AU - Nagasaki, Keisuke

AU - Horikawa, Reiko

AU - Nagai, Toshiro

AU - Tsuchiya, Takayoshi

AU - Suzuki, Erina

AU - Miyado, Mami

AU - Hata, Kenichiro

AU - Nakabayashi, Kazuhiko

AU - Hayashi, Keiko

AU - Matsubara, Yoichi

AU - Baba, Takashi

AU - Morohashi, Ken Ichirou

AU - Igarashi, Arisa

AU - Ogata, Tsutomu

AU - Takada, Shuji

AU - Fukami, Maki

PY - 2015/1/1

Y1 - 2015/1/1

N2 - SOX9 haploinsufficiency underlies campomelic dysplasia (CD) with or without testicular dysgenesis. Current understanding of the phenotypic variability and mutation spectrum of SOX9 abnormalities remains fragmentary. Here, we report three patients with hitherto unreported SOX9 abnormalities. These patients were identified through molecular analysis of 33 patients with 46,XY disorders of sex development (DSD). Patients 1–3 manifested testicular dysgenesis or regression without CD. Patients 1 and 2 carried probable damaging mutations p.Arg394Gly and p.Arg437Cys, respectively, in the SOX9 C-terminal domain but not in other known 46,XY DSD causative genes. These substitutions were absent from ~120,000 alleles in the exome database. These mutations retained normal transactivating activity for the Col2a1 enhancer, but showed impaired activity for the Amh promoter. Patient 3 harbored a maternally inherited ~491 kb SOX9 upstream deletion that encompassed the known 32.5 kb XY sex reversal region. Breakpoints of the deletion resided within nonrepeat sequences and were accompanied by a short-nucleotide insertion. The results imply that testicular dysgenesis and regression without skeletal dysplasia may be rare manifestations of SOX9 abnormalities. Furthermore, our data broaden pathogenic SOX9 abnormalities to include C-terminal missense substitutions which lead to target-gene-specific protein dysfunction, and enhancer-containing upstream microdeletions mediated by nonhomologous end-joining.

AB - SOX9 haploinsufficiency underlies campomelic dysplasia (CD) with or without testicular dysgenesis. Current understanding of the phenotypic variability and mutation spectrum of SOX9 abnormalities remains fragmentary. Here, we report three patients with hitherto unreported SOX9 abnormalities. These patients were identified through molecular analysis of 33 patients with 46,XY disorders of sex development (DSD). Patients 1–3 manifested testicular dysgenesis or regression without CD. Patients 1 and 2 carried probable damaging mutations p.Arg394Gly and p.Arg437Cys, respectively, in the SOX9 C-terminal domain but not in other known 46,XY DSD causative genes. These substitutions were absent from ~120,000 alleles in the exome database. These mutations retained normal transactivating activity for the Col2a1 enhancer, but showed impaired activity for the Amh promoter. Patient 3 harbored a maternally inherited ~491 kb SOX9 upstream deletion that encompassed the known 32.5 kb XY sex reversal region. Breakpoints of the deletion resided within nonrepeat sequences and were accompanied by a short-nucleotide insertion. The results imply that testicular dysgenesis and regression without skeletal dysplasia may be rare manifestations of SOX9 abnormalities. Furthermore, our data broaden pathogenic SOX9 abnormalities to include C-terminal missense substitutions which lead to target-gene-specific protein dysfunction, and enhancer-containing upstream microdeletions mediated by nonhomologous end-joining.

UR - http://www.scopus.com/inward/record.url?scp=84991564060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991564060&partnerID=8YFLogxK

U2 - 10.1002/mgg3.165

DO - 10.1002/mgg3.165

M3 - Article

AN - SCOPUS:84991564060

VL - 3

SP - 550

EP - 557

JO - Molecular genetics & genomic medicine

JF - Molecular genetics & genomic medicine

SN - 2324-9269

IS - 6

ER -